Evidence map›Paper›PMID 33579728›Full record

ArticleCancer immunology research2021

Targeting PIM1-Mediated Metabolism in Myeloid Suppressor Cells to Treat Cancer.

Gang Xin, Yao Chen, Paytsar Topchyan, Moujtaba Y Kasmani, Robert Burns, Peter J Volberding, Xiaopeng Wu, Alexandra Cohn, Yiliang Chen, Chien-Wei Lin and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 82 citations in OpenAlex.

  1. Article
  2. Macrophage PIM1 Drives Atherosclerosis by Enhancing Foam Cell Formation Via CD36.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  3. Review
  4. Review
  5. Docosahexaenoic acid supplementation inhibits monocyte exhaustion memory formation during sepsis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Myeloid-derived suppressor cells modulation in the context of tumor microenvironment for gastric cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Review
  10. Article
  11. Myeloid metabolism and its role in immunotherapy of cancer.Journal for immunotherapy of cancer · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Gang XinVersiti Blood Research Institute, Milwaukee, Wisconsin. gang.xin@osumc.edu weiguo.cui@bcw.edu.
Yao ChenVersiti Blood Research Institute, Milwaukee, Wisconsin.
Paytsar TopchyanVersiti Blood Research Institute, Milwaukee, Wisconsin.ORCID 0000-0002-3902-7652
Moujtaba Y KasmaniVersiti Blood Research Institute, Milwaukee, Wisconsin.ORCID 0000-0002-5753-5335
Robert BurnsVersiti Blood Research Institute, Milwaukee, Wisconsin.
Peter J VolberdingVersiti Blood Research Institute, Milwaukee, Wisconsin.
Xiaopeng WuVersiti Blood Research Institute, Milwaukee, Wisconsin.
Alexandra CohnDepartment of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin.
Yiliang ChenVersiti Blood Research Institute, Milwaukee, Wisconsin.
Chien-Wei LinDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.ORCID 0000-0003-4023-7339
Ping-Chih HoDepartment of Oncology, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0003-3078-3774
Roy SilversteinVersiti Blood Research Institute, Milwaukee, Wisconsin.
Michael B DwinellDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, Wisconsin.
Weiguo CuiVersiti Blood Research Institute, Milwaukee, Wisconsin. gang.xin@osumc.edu weiguo.cui@bcw.edu.
Medical College of Wisconsin · USVersiti Blood Center of Wisconsin · USLudwig Cancer Research · CHThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute · US

Funding

Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
Phenotypic, Functional and Transcriptional Heterogeneity in T Cell ExhaustionR01AI148403 · NIAID · VERSITI WISCONSIN, INC. · PI WEIGUO CUI · 2020 to 2026
$3.1M
The Cellular and Transcriptional Control of CD8 T Cell Functional Adaptation to Chronic VirusesR01AI125741 · NIAID · VERSITI WISCONSIN, INC. · PI CUI, WEIGUO · 2016 to 2020
$2.1M
Biased chemokine receptor signaling in cancer progressionR01CA226279 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI DWINELL, MICHAEL B · 2019 to 2023
$1.9M
Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophagesR01HL153397 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI CUI, WEIGUO, SILVERSTEIN, ROY L · 2021 to 2024
$1.7M
Reprogramming tumor-reactive CD8 T cells by targeting the IL-21-BATF pathway to treat melanomaF30CA246920 · NCI · VERSITI WISCONSIN, INC. · PI TOPCHYAN, PAYTSAR · 2020 to 2023
$200k
Mechanistic study of TCR signaling strength in CD8 T cell differentiation during pathogenesis of T1DMF30DK127526 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI KASMANI, MOUJTABA Y · 2020 to 2023
$198k
NCI NIH HHS F30 CA246920NCI NIH HHS R01 CA226279NHLBI NIH HHS R01 HL153397NIAID NIH HHS R01 AI125741NIAID NIH HHS R01 AI148403NIDDK NIH HHS F30 DK127526NIGMS NIH HHS T32 GM080202
6 · The paper itself

Abstract

There is a strong correlation between myeloid-derived suppressor cells (MDSC) and resistance to immune checkpoint blockade (ICB), but the detailed mechanisms underlying this correlation are largely unknown. Using single-cell RNA sequencing analysis in a bilateral tumor model, we found that immunosuppressive myeloid cells with characteristics of fatty acid oxidative metabolism dominate the immune-cell landscape in ICB-resistant subjects. In addition, we uncovered a previously underappreciated role of a serine/threonine kinase, PIM1, in regulating lipid oxidative metabolism via PPARγ-mediated activities. Enforced PPARγ expression sufficiently rescued metabolic and functional defects of

Indexed as

AnimalsB7-H1 AntigenBiphenyl CompoundsCD8-Positive T-LymphocytesCell Line, TumorDrug Resistance, NeoplasmFemaleHumansImmune Checkpoint InhibitorsImmunotherapyMaleMiceMice, Inbred C57BLMyeloid-Derived Suppressor CellsNeoplasms, ExperimentalProto-Oncogene Proteins c-pim-1AZD1208B7-H1 AntigenBiphenyl CompoundsImmune Checkpoint InhibitorsPIM1 protein, humanProto-Oncogene Proteins c-pim-1Thiazolidines

Identifiers

PMID33579728
PMCPMC8137571
OpenAlexW3127363058

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.